Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Forbion Capital Partners
Biotech
Why investors are staying loyal to European biotech in 2023
With VC firms Forbion and BGV announcing their largest biopharma funds to date, how is investor interest in European biotechs holding up?
James Waldron
Oct 2, 2023 3:00am
Forbion raises €470M fund, eyes bets enabled by market crash
Jun 9, 2022 2:00am
Belgian bio Precirix nabs $88M for radiopharmaceuticals in HER2
Mar 16, 2022 3:00am
Armgo bags $35M for phase 2 heart rhythm study
Dec 20, 2021 7:00am
Pfizer, Novartis back $119M Anaveon series B for phase 2 trials
Dec 16, 2021 12:57pm
Restore your ABCs: Rectify nabs $100M, Vertex founding scientist
Oct 14, 2021 7:00am